Evolus Inc. (EOLS)
NASDAQ: EOLS
· Real-Time Price · USD
9.93
0.00 (0.00%)
At close: Jun 16, 2025, 3:59 PM
10.01
0.80%
After-hours: Jun 16, 2025, 07:26 PM EDT
0.00% (1D)
| Bid | 9.8 |
| Market Cap | 640.24M |
| Revenue (ttm) | 275.01M |
| Net Income (ttm) | -56.2M |
| EPS (ttm) | -0.89 |
| PE Ratio (ttm) | -11.16 |
| Forward PE | 17.44 |
| Analyst | Buy |
| Ask | 10.25 |
| Volume | 579,772 |
| Avg. Volume (20D) | 1,021,611 |
| Open | 9.95 |
| Previous Close | 9.93 |
| Day's Range | 9.81 - 10.07 |
| 52-Week Range | 8.67 - 17.82 |
| Beta | 0.99 |
About EOLS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EOLS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EOLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+1.29%
Evolus Shares Are Trading Lower After The Company ...
Unlock content with
Pro Subscription
4 months ago
+5.47%
Evolus shares are trading higher after the company announced FDA approval of Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels.
